Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000504507 | SCV000592965 | likely benign | not specified | 2017-01-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000977798 | SCV001125719 | likely benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002266970 | SCV002522399 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant (rs150956385) in MODY yet. | |
Clinical Genomics, |
RCV002266971 | SCV002522400 | uncertain significance | Transitory neonatal diabetes mellitus | criteria provided, single submitter | research | Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant (rs150956385) in neonatal diabetes yet. | |
Prevention |
RCV004541548 | SCV004775507 | likely benign | ABCC8-related disorder | 2020-02-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |